What is Exagen Inc.'s restricted cash?

Exagen Inc. (XGN) reported restricted cash of $200K in Q1 2026.

How has Exagen Inc.'s restricted cash changed year-over-year?

Exagen Inc.'s restricted cash decreased by 0.0% year-over-year, from $200K to $200K.

What is the long-term trend for Exagen Inc.'s restricted cash?

Over 5 years (2020 to 2025), Exagen Inc.'s restricted cash has grown at a 14.9% compound annual growth rate (CAGR), from $100K to $200K.

What does restricted cash mean?

Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.

Exagen Inc. XGN Restricted Cash

Restricted Cash at other companies

Avalo TherapeuticsAVTX

$147K+137%

CareDxCDNA

$551K+0.2%

Janux TherapeuticsJANX

$816K0.0%

Bio-Rad LaboratoriesBIO

——

RevvityRVTY

——

Agilent TechnologiesA

——

Other financials

Income statement

See full

Revenue$17.3M+11.7%

Gross profit$10.2M+11.9%

Operating income-$3.4M-1.5%

Net income-$4.0M-5.7%

EPS (diluted)-$0.17+15.0%

Balance sheet

See full

Cash & equivalents$21.7M+90.6%

Total debt$27.1M+15.8%

Total equity$14.4M+125%

Total assets$52.0M+28.9%

Cash flow

See full

Operating cash flow-$10.4M+2.4%

CapEx$228.0K+102%

Free cash flow-$10.6M+1.3%

Valuation

See full

Market cap$112.34M-26.5%

Enterprise value$117.78M-20.3%

P/S1.6×-1.0×

Profitability

See full

Gross margin58.3%-1.0pp

Operating margin-20.6%-2.9pp

Net margin-29.5%+2.5pp

FCF margin-27.5%—

Returns & leverage

See full

Return on equity-193.6%+355pp

Debt / equity1.9×-1.8×

Current ratio3.5×+1.1×

Where this comes from

Reported directly by Exagen Inc. in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCash.

The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exagen Inc.'s restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Exagen Inc.'s restricted cash?: Exagen Inc. (XGN) reported restricted cash of $200K in Q1 2026.
How has Exagen Inc.'s restricted cash changed year-over-year?: Exagen Inc.'s restricted cash decreased by 0.0% year-over-year, from $200K to $200K.
What is the long-term trend for Exagen Inc.'s restricted cash?: Over 5 years (2020 to 2025), Exagen Inc.'s restricted cash has grown at a 14.9% compound annual growth rate (CAGR), from $100K to $200K.
What does restricted cash mean?: Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.